Abstract
Using zymography and computer assisted image analysis, we have measured the levels of type IV collagenases in biopsies from normal breast, and benign and malignant breast disease. The 92 kDa form was present in three of 11 cases of normal/benign disease, three of nine grade I tumours, four of 12 grade II tumours, but 11 of 11 grade III tumours. Mean levels were higher in grade III tumours (P < 0.0001). When the levels of 72 kDa collagenase and its active 62 kDa form were considered together, there was no difference between the benign and malignant cases (P = 0.55), but the amount of active enzyme, considered as a proportion of the 62 + 72 kDa forms, was significantly higher in malignant disease (P = 0.003). There was also a trend towards a higher proportion of active enzyme with increasing tumour grade (P < 0.0001). In situ hybridisation and immunohistochemistry studies showed that that mRNA and protein for the 92 kDa enzyme was primarily found in the tumour stroma. mRNA for the 72 kDa enzyme was also found in stromal areas. This study demonstrates a clear relationship between production of Type IV collagenases and malignant breast disease. Inhibitors of these enzymes may be of value in preventing metastatic disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davies, B., Miles, D., Happerfield, L. et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67, 1126–1131 (1993). https://doi.org/10.1038/bjc.1993.207
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.207
This article is cited by
-
In Vitro Analysis of Bacosine as Novel Therapeutic Agent for Murine Breast Cancer
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences (2019)
-
Proinvasive extracellular matrix remodeling for tumor progression
Archives of Pharmacal Research (2019)
-
Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis
Cancer Microenvironment (2016)
-
T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions
Tumor Biology (2014)
-
Simultaneous demonstration of gelatinolytic activity, morphology, and immunohistochemical reaction using zymography film
Medical Molecular Morphology (2013)